University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that the school will receive a $29 million research award over four years from the National Institutes of Health to lead a multicenter trial that aims to improve health outcomes in people who inject opioid drugs and are hospitalized with infectious complications of their drug use.
Fungal and bacterial pathogens can cause bloodstream infections (BSI), are a persistent and deadly threat to both civilian and military populations,1, 2 and are particularly prevalent in the military due to increased risk of infection following trauma. These infections can be uniquely challenging due to delays in diagnosis, antibiotic resistance and toxicity of treatments, especially for fungal infections. But what if you could have a Roomba-like treatment circulating within your blood t.